Result-Analysis-Elite-Wealth

SRF Limited, a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates, Engaged in the manufacturing of industrial and specialty intermediates. The company is  working across 13 manufacturing plants in India and one each in Thailand, South Africa and Hungary, the company exports to 100+ countries. Equipped with state-of-the-art R&D facilities, SRF has filed 481 patents for R&D and technology so far, of which 151 have been granted.

Result Analysis:   SRF Limited

 (CMP: Rs. 2,935 )

Result Update: Q4FY25

    Open FREE* Demat & Trading Account & ₹0 AMC for first year

    Stay Updated! We'd love to keep you updated with the latest news, exclusive offers, our products, and valuable insights. Please give your consent to receive messages and emails from us.


    Stock Details
    Market Cap. (Cr.) 87,014
    Equity (Cr.) 297
    Face Value 10
    52 Wk. high/low 3098/2089
    BSE Code 503806
    NSE Code SRF
    Book Value (Rs) 425.92
    Sector Chemicals

     

    Key Ratios
    ROCE (%): 13.89
    ROE (%): 10.96
    EPS: 42.20
    P/BV: 6.89
    P/E: 69.54
    D/E 0.37

    Result Highlights:

    • Revenue from operations stood at Rs 4313.34 cr in Q4FY25 up 20.8% compare to Rs 3569.74 cr in Q4FY24 on YoY basis and up 23.54% from Rs 3491.31 cr in Q3FY25 on QoQ basis.
    • It has reported EBIDTA of Rs 957.41 cr in Q4FY25 increased with the growth rate of 37.6% from Rs 695.82 cr in Q4FY24 on YoY basis and on QoQ increased 54.52% from Rs 619.57 cr in Q3FY25. And EBIDTA Margin improved of 22.20% in Q4FY25 from 19.49% in Q4FY24 on YoY basis and from 17.75% in Q3FY25 on QoQ basis.
    • The company has reported PAT of Rs 526.06 cr in Q4FY25 reflected 24.6% up side from Rs 422.21 cr in Q4FY24 on YoY basis and increased 94.1% from Rs 271.08 cr in Q3FY25 on QoQ basis.
    • The Chemicals Business reported an increase of 30% in its segment revenue from Rs 1,816 in Q4FY24 crore to Rs 2,355 crore during Q4FY25.
    • The Performance Films & Foil Business reported an increase of 19% in its segment revenue from Rs 1,182 crore in Q4FY24 to Rs 1,412 crore during Q4FY25.
    • The Technical Textiles Business reported a decrease of 2% in its segment revenue from Rs 469 in Q4FY24 crore to Rs 458 crore during Q4FY25.
    • In Q4FY25, the performance of the Fluorochemicals Business was robust due to strong domestic demand for refrigerants, particularly for Room Air Conditioners, resulting in record-high domestic sales of refrigerant gases.
    • The Other Businesses reported a decrease of 18% in its segment revenue from Rs 106 in Q4FY24 crore to Rs 87 crore in Q4FY25. SRF retained its market leadership in Coated Fabrics by boosting sales of value-added products despite weak demand for food-grade liners.

    Financial Performance:

    Shareholding Pattern:

    Particulars (In %) Q4FY25 Q4FY24
    Promoter 50.26 50.30
    FIIs 19.68 20.47
    DIIs 18.43 15.98
    Public & Other 11.59 13.24
    Government 0.04

    Management Commentary:

    • The company’s core chemicals business saw “reasonable recovery” in the chemicals business during the March quarter and expects this recovery to pick-up pace during the second half of the current financial year.
    • The company enters FY26 with positive momentum; however, management maintains a stance of cautious optimism as the technical textiles segment continues to face headwinds from low-cost imports.
    • The demand for Polyester Tyre Cord Fabric and Polyester Industrial Yarn remained robust, while volumes of Nylon Tyre Cord Fabric were flat. The performance of Belting Fabrics was affected by the influx of low-cost imports from China, which had an impact on the overall performance of the Business.

    Outlook:

    SRF Limited enters FY26 with positive momentum, supported by a strong recovery in its core Chemicals and Fluorochemicals businesses. Management expects this recovery to accelerate in the second half of the year, driven by sustained demand in specialty chemicals and refrigerants. The Performance Films & Foils segment is likely to benefit from improved capacity utilization and a focus on value-added products. However, the company remains cautiously optimistic due to challenges in the Technical Textiles segment, where low-cost imports, particularly from China, continue to pressure margins. Despite this, SRF is well-positioned to leverage its R&D capabilities and global footprint for sustained growth .It has posted an EPS of Rs 42.20 in FY25. The stock currently trading at a P/E of 69.54x and P/B of 6.89x.

    Results:

     Particulars (In Rs. Cr.) Q4FY25 Q4FY24 Q3FY25 YoY% QoQ% FY25 FY24 YoY%
    Net Sales 4215.17 3505.92 3406.69 20.2 23.7 14358.15 12910.35 11.2
    Other Operating Income 98.17 63.82 84.62 53.8 16.0 334.92 228.17 46.8
    Other Income 34.49 23.39 39.64 47.5 -13.0 132.72 83.02 59.9
    Total Income 4347.83 3593.13 3530.95 21 23.1 14825.79 13221.54 12.1
    Total Expenditure 3355.93 2873.92 2871.74 16.8 16.9 11974.63 10554.41 13.5
    EBIDT 991.9 719.21 659.21 37.9 50.5 2851.16 2667.13 6.9
    Interest 89.39 90 96.25 -0.7 -7.1 375.96 302.29 24.4
    EBDT 902.51 629.21 562.96 43.4 60.3 2475.2 2364.84 4.7
    Depreciation 195.15 185.89 194.26 5 0.5 771.5 672.62 14.7
    EBT 707.36 443.32 368.7 59.6 91.9 1703.7 1692.22 0.7
    Tax 181.3 21.11 97.62 758.8 85.7 452.92 356.51 27
    PAT 526.06 422.21 271.08 24.6 94.1 1250.78 1335.71 -6.4
    Source: Company website, EWL Research

     

    Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

    Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

    For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

    Disclosure Appendix

    Analyst Certification (For Reports)

    Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

    The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

    As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

    • all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
    • no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

    Research Excerpts

    This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

    Company-Specific Disclosures

    Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

    Options related research:

    If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

    Other Disclosures

    All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

    Ownership and material conflicts of interest Disclosure

    Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of an y company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

    Country Specific Disclosures

    India – For private circulation only, not for sale. Legal Entities Disclosures

    Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

    EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

    1. Reports
    2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
    • EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
    • EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
    1. Compensation
    • EWL or its associates have not received any compensation from the subject company in the past twelve months;
    • EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
    • EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage  services from the subject company in the past twelve months;
    • EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
    • EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research 3 In respect of Public Appearances
    • EWL or its associates have not received any compensation from the subject company in the past twelve months;
    • The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL